JORGE CASTILLO to Multiple Myeloma
This is a "connection" page, showing publications JORGE CASTILLO has written about Multiple Myeloma.
Connection Strength
5.336
-
HOLA! from Latin America to the myeloma world. Br J Haematol. 2020 02; 188(3):349-350.
Score: 0.564
-
IgM myeloma: A multicenter retrospective study of 134 patients. Am J Hematol. 2017 Aug; 92(8):746-751.
Score: 0.485
-
Risk factors for progression from smoldering into active myeloma: additional insights from a population-based study. Eur J Haematol. 2016 Sep; 97(3):217-8.
Score: 0.461
-
Secondary malignancies in patients with multiple myeloma, Waldenstr?m macroglobulinemia and monoclonal gammopathy of undetermined significance. Leuk Lymphoma. 2017 04; 58(4):773-780.
Score: 0.460
-
Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice. Am J Hematol. 2016 06; 91(6):575-80.
Score: 0.450
-
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients. Leuk Lymphoma. 2016 09; 57(9):2071-6.
Score: 0.440
-
No association between cigarette smoking and incidence of plasma cell myeloma: a meta-analysis of 17 observational studies. Am J Hematol. 2012 Jul; 87(7):729-31.
Score: 0.342
-
Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies. Blood. 2012 May 24; 119(21):4845-50.
Score: 0.340
-
Lymphoplasmacytic lymphoma and multiple myeloma coexisting in the same patient: a case series and literature review. Leuk Lymphoma. 2024 Jul; 65(7):943-949.
Score: 0.194
-
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma. J Clin Oncol. 2023 03 01; 41(7):1383-1392.
Score: 0.177
-
Primary refractory multiple myeloma: a real-world experience with 85 cases. Leuk Lymphoma. 2020 12; 61(12):2868-2875.
Score: 0.150
-
Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients. Leuk Lymphoma. 2020 08; 61(8):1885-1893.
Score: 0.148
-
A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma. Am J Hematol. 2020 05; 95(5):503-509.
Score: 0.147
-
Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients. Am J Hematol. 2019 10; 94(10):1132-1140.
Score: 0.141
-
Outcomes of secondary solid tumor malignancies among patients with myeloma: A population-based study. Cancer. 2019 02 15; 125(4):550-558.
Score: 0.134
-
Clinical characteristics and treatment outcomes in IgE multiple myeloma: A case-control study. Am J Hematol. 2018 09; 93(9):E238-E241.
Score: 0.132
-
Multiple myeloma in patients up to 30?years of age: a multicenter retrospective study of 52 cases. Leuk Lymphoma. 2019 02; 60(2):471-476.
Score: 0.131
-
Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients. Leuk Lymphoma. 2019 01; 60(1):118-123.
Score: 0.131
-
Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study. Ann Hematol. 2017 Oct; 96(10):1693-1698.
Score: 0.123
-
Plasma fatty acid profile in multiple myeloma patients. Leuk Res. 2015 Apr; 39(4):400-5.
Score: 0.103
-
CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies. Expert Opin Investig Drugs. 2012 Jan; 21(1):15-22.
Score: 0.083